Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q4 2024 investor letter. A ...
Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...
1d
Zacks Investment Research on MSNDXCM Inks Deal With Nanowear to Boost CGM Application Beyond DiabetesDexCom DXCM recently signed a licensing and data partnership with a privately held healthcare-at-home digital diagnostics company — Nanowear. Per the terms of the agreement, Nanowear will use glucose ...
The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...
Explore more
The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...
Eligible residents living with diabetes in Saskatchewan who rely on any type of insulin may be eligible to receive coverage ...
Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...
Here are three highlights from the first day of the conference: 1. Dexcom previews new data for 15-day glucose monitor Dexcom ...
Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments.
Connacht will be without captain Cian Prendergast against Cardiff after he was ruled out due to a head injury sustained in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results